Philadelphia, PA, United States of America

Kimberly-Anne Mattia


Average Co-Inventor Count = 3.5

ph-index = 2

Forward Citations = 21(Granted Patents)


Location History:

  • Philadelphia, PA (US) (2014 - 2018)
  • Plymouth Meeting, PA (US) (2023)

Company Filing History:


Years Active: 2014-2023

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Inventor Kimberly-Anne Mattia: A Pioneer in Antibody Research**

Introduction

Kimberly-Anne Mattia, a prominent inventor based in Philadelphia, PA, has made significant contributions to the field of biomedical research. With three patents to her name, she has developed innovative solutions that address pressing health challenges, particularly in the realm of infectious diseases and metabolic conditions.

Latest Patents

One of Kimberly-Anne's latest patents focuses on the development of glucose transporter 4 (GLUT4) antibodies. This technology encompasses methods for making these antibodies and their various applications in medical treatments. Her work provides novel antibodies and compositions that can potentially revolutionize approaches to conditions such as diabetes.

In addition, she holds a patent for antibodies against the chikungunya virus. This innovative patent details neutralizing antibodies that target the virus, including essential methods for identifying these antibodies. Her research includes specific binding to the CHIKV E1, E2, and E3 proteins, as well as the identification of the epitope regions within these proteins, which could lead to impactful treatments in managing chikungunya infections.

Career Highlights

Kimberly-Anne has built her career on a strong foundation of scientific research and development. She has been associated with notable institutions such as Integral Molecular, Inc., where she contributed to advanced projects in antibody research, and Blood Systems Research Institute, focusing on novel therapeutic applications.

Collaborations

Throughout her career, Kimberly-Anne has collaborated with esteemed colleagues, including Benjamin J. Doranz and Bridget Puffer. These partnerships have fostered a rich exchange of ideas and breakthroughs that further enhance the landscape of antibody research.

Conclusion

Kimberly-Anne Mattia stands out as an inventor whose work not only reflects her dedication to scientific advancement but also addresses critical global health issues. Her innovative patents and collaborative spirit highlight her role as a key player in the continuous fight against diseases, paving the way for future researchers and inventors in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…